This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
| p/e | p/bv | ROE | dy | market cap |
net margin |
|
|---|---|---|---|---|---|---|
| 103.71 | 6.69 | 6.45% | 2.31% | $ 542.92 B | 21.76% | |
| 52.78 | 1.57 | 2.97% | 6.90% | $ 141.82 B | 18.60% | |
| 535.81 | -56.32 | -10.51% | 3.20% | $ 372.39 B | 4.63% | |
| 26.47 | 6.33 | 23.91% | 4.17% | $ 198.78 B | 50.15% | |
| 91.32 | 5.94 | 6.50% | 1.76% | $ 281.27 B | 20.15% | |
| 79.63 | 6.87 | 8.63% | 2.46% | $ 160.94 B | 29.04% | |
| 43.39 | 5.78 | 13.32% | 4.39% | $ 116.17 B | 23.30% | |
| 52.11 | 9.69 | 18.59% | 2.74% | $ 31.32 B | 26.57% | |
| 99.86 | 2.31 | 2.31% | 0.51% | $ 72.62 B | 20.17% | |
| 52.78 | 36.06 | 68.32% | 0.00% | $ 7.92 B | 39.83% | |
| 96.87 | 19.17 | 19.79% | 2.96% | $ 176.21 B | 21.11% | |
| 55.17 | -111.26 | -201.68% | 0.42% | $ 92.79 B | 1.75% | |
| 53.72 | 1.92 | 3.57% | 0.00% | $ 1.75 B | 15.08% | |
| 107.61 | 5.73 | 5.33% | 0.00% | $ 110.99 B | 34.53% | |
| 114.64 | -17.12 | -14.93% | 1.05% | $ 45.74 B | 0.65% | |
| 43.06 | 5.00 | 11.61% | 0.00% | $ 1.95 B | 39.59% | |
| 88.77 | 1.52 | 1.71% | 0.00% | $ 28.36 B | 12.89% |
Average Investor10 user rating
4.0
(0 people)
Founded: 2016
Time since IPO - 8 years
Employees
Urovant Sciences Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-145.62 Millions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Urovant Sciences Ltd. reported $- in revenue, generating net income of $-163.71 Millions.
Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.
The company trades under the ticker UROV.
Market cap
$ -
$ -
Net worth
$ -145.62 Millions
$ -145,617,000.00
Assets
$ 108.89 Millions
$ 108,887,000.00
Total Shares Outstanding
32.53 Millions
32,533,000
Average Daily Trading Volume
$ 395.97 Thousand
$ 395,973.00
Sector
Health Care
Industry
Biotechnology
Shares
0.00
0.00%
-893.55%
0.00
55.17
0.42%
-201.68%
-111.26
114.64
1.05%
-14.93%
-17.12
103.71
2.31%
6.45%
6.69
-64.94
2.98%
-9.23%
5.99
91.32
1.76%
6.50%
5.94
535.81
3.20%
-10.51%
-56.32
26.47
4.17%
23.91%
6.33
0.00
0.00%
-893.55%
0.00
55.17
0.42%
-201.68%
-111.26
114.64
1.05%
-14.93%
-17.12
103.71
2.31%
6.45%
6.69
-64.94
2.98%
-9.23%
5.99
91.32
1.76%
6.50%
5.94
535.81
3.20%
-10.51%
-56.32
26.47
4.17%
23.91%
6.33
A cotação de Urovant Sciences (UROV) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. negociando na casa dos $ 0.00 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.
Urovant Sciences (UROV) did not pay dividends over the past year.
Atualmente, Urovant Sciences (UROV) está cotada a $ 0.00, com um P/L de 0.00, This represents a 0% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of -%. The total shareholder return over the same period was 0.00%.
Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.
You can buy Urovant Sciences (UROV) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol UROV and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.
Over the past month, Urovant Sciences (UROV) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.
Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de -%.
Se você quisesse comprar 100 ações de Urovant Sciences (UROV) hoje, o investimento total seria de $ 0.00, com base na cotação atual de $ 0.00.
Based on historical performance, the investment would have grown to approximately:
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Register
Already have an account? Login
Register
Register for free to continue accessing Investor10.
Already have an account? Login
Tesla
Dividend Calendar
Stock Rankings
ETF Rankings
Crypto Rankings
